TNFSF10 and glioblastoma: Importantly, combined use of lovastatin and TRAIL can synergistically inhibit Erk activation in vitro, and this is consistent with the in vivo data that combined treatment with lovastatin and TRAIL can effectively inhibit tumor growth in mouse model of human glioblastoma.